PDF herunterladen
kleintier konkret 2019; 22(01): 21-30
DOI: 10.1055/a-0753-9652
CVE-Fortbildung
Georg Thieme Verlag KG Stuttgart · New York

Pulmonale Hypertension beim Hund: Ursachen, Therapie und Prognose

Katrin Baldauf
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
27. Februar 2019 (online)

Auch verfügbar auf
    Lizenzen und Reprints Alle Artikel dieser Rubrik

Dyspnoe, Synkope, Kongestion, unspezifische Symptome – Diagnostik und Therapie bei pulmonaler Hypertension sind komplex. Die breite Verfügbarkeit von Echokardiografie zur Druckbestimmung gestattet die Diagnosestellung. Zahlreiche Ursachen sind möglich und die Therapie ist eine Herausforderung.
 

  • Literatur

  • 1 Schober KE, Baade H. Doppler echocardiographic prediction of pulmonary hypertension in West Highland white terriers with chronic pulmonary disease. J Vet Intern Med 2006; 20: 912-920
    CrossrefPubMedSuche in Google Scholar
  • 2 McLaughlin VV, Archer SL, Badesch DB. et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation 2009; 119 (16) 2250-2294
    CrossrefPubMedSuche in Google Scholar
  • 3 Simonneau G, Gatzoulis MA, Adatia I. et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013; 62: 34-41
    Suche in Google Scholar
  • 4 Johnson L, Boon J, Orton EC. Clinical characteristics of 53 dogs with Doppler-derived evidence of pulmonary hypertension: 1992–1996. J Vet Intern Med 1999; 13: 440-447
    PubMedSuche in Google Scholar
  • 5 Pyle RL, Abbott J, MacLean H. Pulmonary hypertension and cardiovascular sequelae in 54 dogs. Intern J Appl Res Vet Med 2004; 2 (02) 99-109
    Suche in Google Scholar
  • 6 Glaus TM, Soldati G, Maurer R. et al. Clinical and pathological characterisation of primary pulmonary hypertension in a dog. Vet Rec 2004; 154: 786-789
    CrossrefPubMedSuche in Google Scholar
  • 7 Zabka TS, Campbell FE, Wilson DW. Pulmonary arteriopathy and idiopathic pulmonary arterial hypertension in six dogs. Vet Pathol 2006; 43: 510-522
    CrossrefPubMedSuche in Google Scholar
  • 8 Jenkins TL, Jennings RN. Pulmonary capillary hemangiomatosis and hypertrophic cardiomyopathy in a Persian cat. J Vet Diagn Invest 2017; 29: 900-903
    CrossrefPubMedSuche in Google Scholar
  • 9 Williams K, Andrie K, Cartoceti A. et al. Pulmonary veno-occlusive disease: a newly recognized cause of severe pulmonary hypertension in dogs. Vet Pathol 2016; 53 (04) 813-822
    CrossrefPubMedSuche in Google Scholar
  • 10 Stepien RL. Pulmonary arterial hypertension secondary to chronic left-sided cardiac dysfunction in dogs. J Small Anim Pract 2009; 50 (01) 34-43
    CrossrefPubMedSuche in Google Scholar
  • 11 Serres FJ, Chetboul V, Tissier R. et al. Doppler echocardiography-derived evidence of pulmonary arterial hypertension in dogs with degenerative mitral valve disease: 86 cases (2001–2005). J Am Vet Med Assoc 2016; 229 (11) 1772-1778
    Suche in Google Scholar
  • 12 Serres F, Chetboul V, Gouni V. et al. Diagnostic value of echo‐Doppler and tissue Doppler imaging in dogs with pulmonary arterial hypertension. J Vet Intern Med 2007; 21 (06) 1280-1289
    CrossrefPubMedSuche in Google Scholar
  • 13 Borgarelli M, Zini E, DʼAgnolo G. et al. Comparison of primary mitral valve disease in German Shepherd dogs and in small breeds. J Vet Cardiol 2004; 6 (02) 27-34
    CrossrefPubMedSuche in Google Scholar
  • 14 Johnson LR, Lappin MR, Baker DC. Pulmonary thromboembolism in 29 dogs: 1985–1995. J Vet Intern Med 1999; 13 (04) 338-345
    PubMedSuche in Google Scholar
  • 15 Johnson RJ. Pulmonary hypertension. In: Luis Fuentes V, Johnson LR, Dennis S. eds. BSAVA Manual of Canine and Feline Cardiorespiratory Medicine. 2nd ed.. Gloucester: British Small Animal Veterinary Association; 2010: 264-267
    CrossrefSuche in Google Scholar
  • 16 Atkins C, Bonagura J, Ettinger S. et al. Guidelines fort he diagnosis and treatment of canine chronic valve disease. J Vet Intern Med 2009; 23 (06) 1142-1150
    CrossrefPubMedSuche in Google Scholar
  • 17 Bach JF, Rozanski EA, MacGregor J. et al. Retrospective evaluation of sildenafil citrate as a therapy for pulmonary hypertension in dogs. J Vet Intern Med 2006; 20: 1132-1135
    CrossrefPubMedSuche in Google Scholar
  • 18 Kellum HB, Stepien RL. Sildenafil citrate therapy in 22 dogs with pulmonary hypertension. J Vet Intern Med 2007; 21: 1258-1264
    CrossrefPubMedSuche in Google Scholar
  • 19 Serres F, Nicolle AP, Tissier R. et al. Efficacy of oral tadalafil, a new long-acting phosphodiesterase-5 inhibitor, for the short-term treatment of pulmonary arterial hypertension in a dog. J Vet Med A Physiol Pathol Clin Med 2006; 53 (03) 129-133
    CrossrefPubMedSuche in Google Scholar
  • 20 Atkinson KJ, Fine DM, Thombs LA. et al. Evaluation of pimobendan and N-terminal probrain natriuretiv peptide in the treatment of pulmonary hypertension secondary to degenerative mitral valve disease in dogs. J Vet Intern Med 2009; 23 (06) 1190-1196
    CrossrefPubMedSuche in Google Scholar
  • 21 Murphy LA, Russell N, Bianco D. et al. Retrospective evaluation of pimobendan and sildenafil therapy for severe pulmonary hypertension due to lung disease and hypoxia in 28 dogs (2007–2013). Vet Med Sci 2017; 3 (02) 99-106
    Suche in Google Scholar
  • 22 Borgeat K, Sudunagunta S, Kaye B. et al. Retrospective evaluation of moderate-to-severe pulmonary hypertension in dogs naturally infected with Angiostrongylus vasorum. J Small Anim Pract 2015; 56 (03) 196-202
    CrossrefPubMedSuche in Google Scholar
  • 23 Borgarelli M, Abbott J, Braz-Ruivo L. et al. Prevalence and prognostic importance of pulmonary hypertension in dogs with myxomatous mitral valve disease. J Vet Intern Med 2015; 29 (02) 569-574
    CrossrefPubMedSuche in Google Scholar